|
|
Resources
PharmaceuticalsModel N to offer revenue tool with Sierra Atlantic (November 20, 2009)
Flu at bay (November 19, 2009)
Glenmark settles patent cases with Medicis Pharma (November 17, 2009)
Torrent inaugurates insulin vial manufacturing unit in Gujarat (November 15, 2009)
Aurobindo, Trident Life merger (November 14, 2009)
Ranbaxy’s AIDS drug gets WHO nod (November 13, 2009)
SC to hear Zenotech case on Dec 2 (November 13, 2009)
Aurobindo gets US nod for drug (November 13, 2009)
Mr Vishal Bali, CEO, Wockhardt Hospitals, Mr Mahesh Kumar K.R., Director, VVN Institute of Managemen (November 13, 2009)
Cipla offers to step-up swine flu drug supplies (November 12, 2009)
Jubilant-Duke varsity pact (November 12, 2009)
US nod for Aurobindo drugs (November 10, 2009)
CDR package: Wockhardt to address creditors’ concerns by month end (November 08, 2009)
Aurobindo drug gets US nod (November 07, 2009)
Celestial Labs to change name (November 07, 2009)
Anti-Malaria vaccine trials (November 07, 2009)
Aurobindo’s share allotment (November 05, 2009)
Vardhman Health on expansion mode (November 05, 2009)
Novartis Venture Funds looking at innovative India opportunities (November 03, 2009)
Bafna Pharma to enter contract research, manufacturing (November 03, 2009)
Zenotech gets CLB nod to call for board meeting (November 02, 2009)
S. Africa nod for Aurobindo drugs (October 30, 2009)
Astec Lifesciences plans IPO for Rs 61.5 cr (October 28, 2009)
Biosimilars will drive growth for Dr Reddy’s, says Chairman (October 28, 2009)
Bharat Biotech, Orissa to develop Konark Park (October 26, 2009)
Apollo Pharma to retail H1N1 drug (October 21, 2009)
Celestial Labs to issue preferential warrants (October 21, 2009)
Pfizer launches book on clinical trials (October 19, 2009)
Glenmark Generics to stop selling codeine sulphate in US (October 15, 2009)
Merck acquires Sanmar’s Bangalore Genei (October 14, 2009)
Merck acquires Sanmar’s Bangalore Genei (October 14, 2009)
DHL to invest $10 m in India’s life sciences sector (October 08, 2009)
GVK Bio, Quantitative in pact (October 08, 2009)
Dr Reddy’s launches two drugs (October 08, 2009)
Dr Reddy’s allots ESOPs (October 06, 2009)
Biocon to buy Gulf Oil's bulk drugs unit (October 02, 2009)
Bharat Bio gets patent for lysostaphin (October 02, 2009)
Reducing debt is Orchid Chemicals’ priority (October 02, 2009)
Worries over Sun-Taro impasse (October 02, 2009)
Taro sues Sun Pharma in US (October 01, 2009)
2 US acquisitions in 3 months and Lupin scouts for more (September 29, 2009)
Biocon in Forbes ‘best’ list (September 26, 2009)
Natco capsules for swine flu (September 26, 2009)
Glenmark may raise funds by selling stake (September 26, 2009)
Strides Arcolab begins retail sales of flu drug (September 26, 2009)
3 subsidiaries to merge with Lupin (September 26, 2009)
Tazo-Pip case: Crucial for Orchid and Wyeth (September 25, 2009)
Apollo Pharmacy turnover set to cross Rs 1,000 cr (September 25, 2009)
Cipla raises Rs 671 crore through QIP (September 24, 2009)
Alembic (Rs 50.2): Buy (September 24, 2009)
Merck, UK body in R&D tie-up for cheaper vaccines (September 19, 2009)
Dr Reddy’s gains 3.6% on stake sale buzz (September 19, 2009)
Glenmark to raise $250 m (September 19, 2009)
`Natflu' for H1N1 flu by Natco (September 19, 2009)
Ranbaxy ties up with S. Korean co (September 18, 2009)
Elder Pharma denies bogus sales, purchases (September 17, 2009)
US nod for Orchid’s drug (September 17, 2009)
Centre taps MNCs for swine flu vaccine as toll crosses 200 (September 16, 2009)
Suven Life secures 2 US patents (September 15, 2009)
US nod for Dr Reddy’s diabetes drug (September 15, 2009)
Mylan drug application (September 15, 2009)
Natco Pharma seeks distribution pacts (September 12, 2009)
Flu boosts Lupin’s immunity drug sales (September 12, 2009)
Biocon, Amylin Pharma tie up to develop new diabetes drug (September 12, 2009)
Swiss nod for 2 Aurobindo drugs (September 08, 2009)
Suven gets first milestone payment from Eli Lilly (September 08, 2009)
Pfizer’s smoking-cessation drug cautions behavioural changes (September 06, 2009)
We are overweight on pharma sector: ICICI Pru MF (September 06, 2009)
Ranbaxy to market generic calcium drug in US (September 04, 2009)
Dr Reddy's allots ESOPs (September 04, 2009)
Apollo may take in partner for pharma biz (September 04, 2009)
Vivimed Labs buys back FCCBs worth $12.5 m (September 03, 2009)
Ranbaxy to sell products of Daiichi Sankyo in Romania (September 03, 2009)
Novartis’ Glivec case to be heard by another Bench (September 01, 2009)
Neuland eyes peptides manufacture (August 28, 2009)
Emami plans to use Chlorophyll for integrating Zandu brands (August 28, 2009)
GSK to bring in Actiprotect mask; no word on Relenza (August 26, 2009)
Suven Life Sciences hits 52-week high (August 26, 2009)
Fortis acquires pan-India presence at reasonable price (August 25, 2009)
USFDA nod for Ranbaxy ulcer drug (August 25, 2009)
Hetero bags Rs 40-cr order to supply A(H1N1) drug (August 22, 2009)
Cryo-Save to make India its Asia-Pacific hub (August 21, 2009)
Zenotech board meet adjourned (August 21, 2009)
Panacea gets Rs 1,000-cr order (August 20, 2009)
Glenmark’s first out-licensed molecule shelved (August 20, 2009)
Divis Labs to pay Rs 6 as dividend (August 18, 2009)
Fresenius Kabi Oncology (Rs 66.4): Buy (August 17, 2009)
‘Flexibility is a must for biotech ventures’ (August 14, 2009)
Ranbaxy enters protein supplements market with ‘Revitalite’ (August 13, 2009)
IICT scientist wins pharma award (August 13, 2009)
Orchid settles Schering lawsuit (August 13, 2009)
Select pharma stocks gain on Tamiflu demand (August 12, 2009)
Aurobindo migraine drug gets US nod (August 12, 2009)
Hetero told to scale up Tamiflu supplies (August 12, 2009)
Ranbaxy’s anti-migraine drug gets USFDA nod (August 12, 2009)
Paras Pharma bets on new products to spur growth (August 12, 2009)
SMS Pharma declares dividend (August 12, 2009)
Granules signs finished dosage pact with MNC (August 11, 2009)
SAT stops Zenotech open offer (August 11, 2009)
Govt steps up efforts to combat swine flu (August 11, 2009)
Prescient Biosciences to train pharma, biotech professionals (August 10, 2009)
Aurobindo relaxants get US nod (August 08, 2009)
Matrix launches cost-effective AIDS drug regimen (August 08, 2009)
Dr Reddy’s launches new cream (August 06, 2009)
Dishman Pharma (Rs 204.30): Buy (August 06, 2009)
Divis Lab allots bonus shares (August 05, 2009)
GVK Bio eyes clinical research deal with multinational co (August 05, 2009)
Probe initiated into dumping of Pen-G Potassium, 6-APA (July 28, 2009)
DSM to make active ingredients for anti-fungal, hypertension drugs (July 25, 2009)
SC clears Daiichi Sankyo open offer to Zenotech (July 25, 2009)
Gland Pharma Chairman’s foundation to start college (July 24, 2009)
Ranbaxy gets Canada’s nod for BP drug (July 23, 2009)
‘Exploit more, explore less’ is Dr Reddy’s strategy in tough conditions (July 23, 2009)
DRL Q1 results point to increasing pressure on revenues (July 23, 2009)
Cadila loses trademark case against Wallace Pharma (July 21, 2009)
LIC exits Pfizer Ltd (July 21, 2009)
No slowdown hiccups (July 20, 2009)
Natco Pharma recalls breast cancer drug (July 19, 2009)
Novartis set to appeal move on Glivec (July 18, 2009)
Wyeth talks to Govt on 7-in-1 vaccine (July 17, 2009)
Ocimum Biosolutions gets US patent (July 17, 2009)
Piramal Life expects first drug launch by 2011 (July 15, 2009)
Cadila, Novavax tie up to bring swine flu vaccine to India (July 11, 2009)
Sun Pharma, Forest settle legal issues on anti-depressant (July 11, 2009)
PerkinElmer bio-pharma centre (July 10, 2009)
Little to cheer about for pharma, chemical sectors (July 10, 2009)
Cipla gets notices for alleged overcharging (July 10, 2009)
Lupin, 2 others face Europe anti-trust probe (July 10, 2009)
Wockhardt debt recast approved (July 10, 2009)
Ranbaxy recalls acne drug from US market (July 10, 2009)
Mahindra Satyam signs deal with GlaxoSmithKline (July 10, 2009)
Pharma institute to come up near Madurai (July 09, 2009)
Dr Reddy’s sees better show from Betapharm this year (July 08, 2009)
Strides Arcolab buys back FCCBs (July 03, 2009)
Jubilant recalls hypertension drug from UK on regulator order (July 03, 2009)
Lupin buys global rights for nasal steroid from Collegium (July 02, 2009)
Vivimed Labs to pay 15% dividend (July 02, 2009)
Make healthcare accessible, affordable (July 01, 2009)
Persistent to tap life sciences (June 30, 2009)
Enhance spending on healthcare sector (June 30, 2009)
Hetero donates oral H1N1 flu drug (June 30, 2009)
GVK Bio in pact with Tokyo varsity (June 30, 2009)
Biological E nod for anthrax vaccine (June 30, 2009)
Biocon ties up with Mylan of US for biogenerics (June 30, 2009)
Wockhardt to sell animal health unit to French company (June 29, 2009)
Astellas to bring in transplant drug (June 25, 2009)
S. Africa nod for Aurobindo drugs (June 25, 2009)
Matrix Labs allots ESOPs (June 25, 2009)
Glenmark Pharma (Rs 234.65): Buy (June 25, 2009)
Dr Reddy’s new drug (June 24, 2009)
Orchid Chem & Pharma (Rs 105.9): Sell (June 22, 2009)
Dumping duty on Vitamin C from China (June 22, 2009)
Piramal exports may touch Rs 800 cr (June 20, 2009)
Advinus seeks approval for trials of new diabetes molecule (June 19, 2009)
Jubilant mulls sale of performance polymer biz (June 17, 2009)
DRL-GSK deal: Cure for both (June 17, 2009)
Swine flu cases in India spike to 30 (June 16, 2009)
Australia’s nod for Aurobindo drug (June 16, 2009)
Teams up with GSK for drug development (June 16, 2009)
Medicis files suit against Ranbaxy (June 14, 2009)
Dr Reddy’s Labs gets USFDA nod for Omeprazole Mg (June 11, 2009)
Kemwell makes Rs 250-cr foray into biopharma (June 10, 2009)
Dr Reddy’s new drug gets nod (June 10, 2009)
Hetero delivers Fluvir to treat 7 lakh patients (June 09, 2009)
Biocon to invest in cell for innovation at ISB (June 09, 2009)
Zydus moves DCGI for new diabetes, obesity drug (June 07, 2009)
Anu’s Lab plans to raise Rs 250 cr (June 06, 2009)
Crisil downgrades Glenmark’s ratings (June 06, 2009)
Unichem looks to establish connection with consumers (June 04, 2009)
Take Solutions deal with Korean co (June 03, 2009)
Wockhardt changes auditor (May 30, 2009)
Biocon unveils long play insulin Basalog (May 30, 2009)
Matrix gets nod to delist shares (May 29, 2009)
Novartis hikes offer price to Rs 450 a share (May 29, 2009)
Aurigene upbeat after Dr Reddy’s rejig (May 27, 2009)
Avesthagen ropes in Harvard for Parsi project (May 27, 2009)
Dr Reddy’s to focus on R&D projects to drive more revenue (May 26, 2009)
Orchid Chemicals (Rs 129.95): Buy (May 26, 2009)
Strides looks at four-fold increase in US revenues this year (May 24, 2009)
Hetero Drugs to consolidate operations in fiscal 2009-10 (May 23, 2009)
Wanted: Safe hands for Health Ministry (May 23, 2009)
Alexandria to invest in Genome Valley (May 22, 2009)
Indoco to supply diabetes tablets to Germany (May 22, 2009)
Dr Reddy’s revamps drug discovery research (May 22, 2009)
Pfizer acquires rights to 60 products of Aurobindo (May 22, 2009)
Ranbaxy buys Ochoa Labs’ skin care range (May 22, 2009)
Dr Reddy’s grants stock options (May 21, 2009)
Claris partners Pfizer to strengthen regulated market presence (May 21, 2009)
Piramal Life starts Phase I trial on diabetes drug (May 21, 2009)
Lonza to set up bio-pharma facility in Hyderabad (May 21, 2009)
Dr Reddy’s to tap rural, north Indian markets for growth (May 20, 2009)
Swine-flu leads health concerns for new govt (May 19, 2009)
Glenmark Pharma (Rs 168): Sell (May 14, 2009)
Cipla's swine flu drug in WHO list (May 14, 2009)
Hetero readies drugs for treating ‘swine flu’ (May 13, 2009)
Lupin settles all patent litigations (May 12, 2009)
Cadila expects Rs 100 cr revenue from Polycap (May 10, 2009)
Ocimum Bio’s test to detect swine flu (May 07, 2009)
Suven Life unit gets USFDA nod (May 07, 2009)
Jubilant in R&D deal with AstraZeneca (May 06, 2009)
Strides joins flu drug suppliers (May 06, 2009)
Jubilant gets US FDA nod to market generic Sestamibi (May 05, 2009)
Ranbaxy recalls antibiotic drug in US market (May 03, 2009)
Matrix Lab to delist from BSE, NSE (May 02, 2009)
Centre to raise Tamiflu stockpile (April 30, 2009)
Biocon eyes biogenerics ride to US (April 29, 2009)
Dr Reddy's anti-acne gel (April 29, 2009)
Swine flu: Centre taps Hetero for generic Tamiflu supply (April 29, 2009)
Shantha Biotech launches oral cholera vaccine (April 27, 2009)
Covidien enters Indian market (April 27, 2009)
Wockhardt CFO, 2 others opt for voluntary debarment (April 23, 2009)
Matrix selected to supply HIV drugs (April 22, 2009)
Cipla does not support Adcock proposal to buy Cipla Medpro (April 19, 2009)
Dr Reddy’s to begin supply to Germany’s health insurance fund (April 17, 2009)
Natco Pharma, Dr Reddy’s in pact for oncology drugs (April 17, 2009)
Divi’s Lab allots stock options (April 16, 2009)
Nektar Therapeutics gets new MD (April 16, 2009)
Troikaa Pharma launches cancer drug (April 16, 2009)
Jubilant Organosys (Rs 120): Buy (April 16, 2009)
Pharma products co formed (April 15, 2009)
Strides to hive off R&D, sterile products entities (April 14, 2009)
Pfizer to raise stake in Indian arm (April 14, 2009)
Glenmark molecule phase I trials (April 14, 2009)
Cipla can benefit if Medpro acquisition goes through (April 10, 2009)
Natco, Lupin tie-up for generic drug to treat kidney failure (April 10, 2009)
Some pharma, FMCG stocks miss current rally (April 10, 2009)
Jubilant arms, Finnish co tie up (April 10, 2009)
Suven Life: Trials of Alzheimer drug (April 10, 2009)
Strides gets US nod for AIDS drug (April 09, 2009)
Granules India changes accounting period (April 09, 2009)
Swiss approval for Aurobindo drug (April 09, 2009)
‘Pharma, auto sectors will lead Indian growth resurgence’ (April 07, 2009)
Zydus files new drug application with USFDA (April 05, 2009)
Khorakiwala is Chairman of CoD (April 04, 2009)
Glaxo SmithKline AGM (April 03, 2009)
Acquisition overdose: Worries over future of pharma industry (April 03, 2009)
Piramal Health to shut down UK plant (April 03, 2009)
Piramal Healthcare move long-term positive (April 03, 2009)
‘Succession plan good for Wockhardt shareholders’ (April 02, 2009)
Wockhardt may go in for restructure of biz, subsidiaries (April 01, 2009)
USFDA nod for Aurobindo AIDS drug (April 01, 2009)
Ranbaxy gets USFDA nod for anti-seizure drug (March 31, 2009)
Shantha board meeting today (March 31, 2009)
Strides Arcolab gets USFDA nod (March 29, 2009)
Matrix Labs likely to delist shares (March 28, 2009)
Ranbaxy's new auditor, director (March 28, 2009)
Lupin acquires 51% stake in Multicare Pharma (March 28, 2009)
Avesthagen to rework pact with ShigaMedix for cervical cancer vaccine (March 28, 2009)
Biocon, Bristol-Myers open R&D centre (March 27, 2009)
Stempeutics eyes stem cell drug in 2011 (March 25, 2009)
Ranbaxy facility gets UK, Australian clearance (March 24, 2009)
Vimta Labs in pact for Ph.D. programme (March 23, 2009)
US FDA nod for Aurobindo drug (March 21, 2009)
Dr Reddy’s revenues cross $150 m in Russia/CIS region (March 21, 2009)
S. Africa okays 3 Aurobindo drugs (March 20, 2009)
Dr Reddy’s to exit small generic drug markets abroad (March 20, 2009)
Strides plants get US cGMP tag (March 19, 2009)
Natco succeeds in opposing Israeli co’s patent application (March 17, 2009)
Medical devices cos want single regulator (March 16, 2009)
Strides ends supply pact with KV Pharma of US (March 14, 2009)
‘Strides Arcolab to launch over 25 products this year’ (March 13, 2009)
Fulford India shares up on open offer hopes (March 13, 2009)
Aurobindo gets nod for HIV drug (March 13, 2009)
Ipca Laboratories (Rs 328.35): Buy (March 12, 2009)
French co to distribute Jubilant arm’s drug in Europe (March 12, 2009)
Pfizer joins Govt’s anti-tobacco efforts (March 11, 2009)
Ranbaxy gets USFDA nod for heart drug (March 10, 2009)
Ranbaxy to sell anti-fungal drug in Australia (March 07, 2009)
Aurobindo Pharma-Pfizer deal: Positive for both companies (March 06, 2009)
Ranbaxy gets USFDA nod for BP drug (March 06, 2009)
Aurobindo drug gets US FDA nod (March 05, 2009)
Zydus unit gets accreditation (March 05, 2009)
Aurobindo Pharma, Pfizer in pact (March 04, 2009)
Bharat Bio’s five-in-one vaccine (March 03, 2009)
Jubilant gets drug approval in Canada (March 03, 2009)
IDPL’s revival plan looks to improve capacity utilisation and develop assets (March 03, 2009)
USFDA move on Ranbaxy will have serious implications (February 27, 2009)
Intas to sell Pemetrexed in India (February 26, 2009)
MSD Pharma offers patient support for diabetes, cervical cancer (February 25, 2009)
Patents yes, but monopoly no (February 25, 2009)
MSD Pharma to raise headcount, partnerships this year (February 24, 2009)
Aurobindo gets nod for HIV drug (February 21, 2009)
USV to sell generic version of cancer drug bicalutamide in US (February 20, 2009)
‘Special allocations required’ (February 17, 2009)
Aurobindo Pharma promoters pledge 39% of equity (February 15, 2009)
Guardian Pharmacy ties up with Singapore healthcare firm (February 12, 2009)
Piramal Life Sciences shares in limelight (February 12, 2009)
Promising drug to cure TB (February 07, 2009)
Concern over access to next-gen AIDS drugs (February 06, 2009)
Dr Reddy’s launches 5 drugs in US (February 06, 2009)
Claris LifeSciences gets award (February 05, 2009)
US drug co may set up R&D centre in Bangalore (February 04, 2009)
Cadila to set up College of Life Sciences (February 04, 2009)
Merck talking to 10 pharma cos for tie-ups (February 03, 2009)
Swiss pharma co Lonza evaluating prospects in India (February 03, 2009)
Biological E’s new facility in AP inaugurated (February 03, 2009)
Zydus gets new approvals (January 31, 2009)
Fear of job cuts casts shadow on Pfizer-Wyeth deal (January 28, 2009)
Celestial Biologicals, GE Healthcare to work on plasma fractionation facility (January 26, 2009)
Zenotech faults Daiichi Sankyo (January 22, 2009)
DRL gets notice on land deal with Sify (January 21, 2009)
Wockhardt gets nod to raise Rs 500 cr (January 20, 2009)
Daiichi Sankyo must honour Rs 160/share commitment: Zenotech (January 20, 2009)
Wockhardt in pact with Swiss co DSM Nutritional (January 18, 2009)
Intas to pump in Rs 160 cr for Gujarat facility (January 17, 2009)
Matrix assigns part of Astrix purchase rights to parent co (January 16, 2009)
Jubilant Biosys ties up with BioLeap (January 14, 2009)
Ciba expected to continue contract with Satyam (January 14, 2009)
Ranbaxy’s respiratory drug clinical trials begin (January 11, 2009)
Sun Pharma rejects Taro’s proposal for higher offer price (January 08, 2009)
Aurobindo gets nod for epilepsy drug (January 07, 2009)
Strides Arcolab gets new HR head (January 06, 2009)
Dr Reddy’s Lab gets new CFO (January 04, 2009)
Strides drug gets USFDA nod (January 03, 2009)
Transgene Biotek gets licence (January 03, 2009)
Govt brings 2 pharma cos under direct control (January 03, 2009)
Aurobindo gets FDA approval for new drug (January 01, 2009)
Zenotech net loss widens to Rs 3.41 cr (November 18, 2009)
Anu’s Laboratories net up 6% (November 02, 2009)
Suven Life Q2 net dips 48% to Rs 2.5 cr (November 02, 2009)
Divi’s Labs Q2 net down 37% (November 02, 2009)
Aurobindo Pharma returns to profits with Rs 103-cr net (November 02, 2009)
Orchid posts lower losses in Q2 (November 01, 2009)
Natco Pharma’s net up 12.6% (October 30, 2009)
Vivimed Labs net up at Rs 8 cr Hyderabad, Oct. 28 (October 29, 2009)
Sun Pharma net profit dips 49% (October 29, 2009)
Formulations biz fuels Zydus Cadila net (October 28, 2009)
Lupin Q2 net profit rises 39% (October 27, 2009)
Emerging markets growth helps Ranbaxy return to black (October 27, 2009)
Krebs Bio posts Rs 6 cr loss in Q2 (October 27, 2009)
Granules net doubles to Rs 6 cr (October 27, 2009)
Vimta Labs net down at Rs 67 lakh (October 25, 2009)
Dr Reddy’s Q2 net surges on revenue growth in generics (October 24, 2009)
Jubilant Organosys’ focus on pharma pays (October 23, 2009)
Biocon Q2 net grows 86%, income 16% (October 23, 2009)
Domestic growth aids Piramal Health (October 23, 2009)
Celestial Lab posts flat net (August 04, 2009)
Strides posts Rs 60-cr net in Q2 (August 01, 2009)
Aurobindo Q1 net trebles (August 01, 2009)
Orchid Chem lowers loss in Q1 (August 01, 2009)
Matrix Labs net down 49% (July 31, 2009)
Wockhardt posts Rs 190-cr loss (July 31, 2009)
Natco Pharma profit up 5% (July 31, 2009)
Suven Life Sciences Q1 net up 36% (July 30, 2009)
Lupin net up 65% at Rs 180 cr (July 30, 2009)
Sun Pharma profits down 57% to Rs 122 cr (July 30, 2009)
GSK Pharma sales rise (July 29, 2009)
Glenmark net profit dips 91% on forex loss (July 28, 2009)
Granules India net doubles (July 28, 2009)
SMS Pharma profits down (July 28, 2009)
Vimta Lab’s net down 26 pc (July 28, 2009)
Ranbaxy moves back into the black (July 25, 2009)
Biocon net up 58% in Q1 on services push (July 24, 2009)
Custom manufacturing under pressure: Piramal (July 23, 2009)
Dr Reddy’s Q1 net more than doubles (July 22, 2009)
Jubilant’s Q1 profit rises to Rs 145 cr (July 16, 2009)
Vivimed Lab’s yearly net up 5% (July 03, 2009)
Natco Q4 net falls marginally (July 02, 2009)
Anu’s Labs Q4 net down (July 01, 2009)
Orchid in red over forex, derivatives losses (June 30, 2009)
Matrix posts Rs 189 cr profit (June 27, 2009)
Divis Labs Q4 net up 13% (June 08, 2009)
Sun Pharma fourth-quarter net falls 45% to Rs 394 cr (May 31, 2009)
Unichem Q4 net rises 50% (May 28, 2009)
Gayatri Bioorganics posts loss in Q4 (May 27, 2009)
Neuland net up at Rs 8 cr in Q4 (May 23, 2009)
Impairment loss offsets revenue growth for Dr Reddy’s (May 20, 2009)
Dr Reddy’s takes Betapharm hit (May 19, 2009)
Torrent Pharma Q4 net down 18% (May 16, 2009)
Lupin net rises 64% in Q4 on all-round growth (May 14, 2009)
Alembic sales rise 11%, net down 90% (May 10, 2009)
Novartis Q4 net down 4% (May 09, 2009)
Avon Organics records profit in Q4 (May 05, 2009)
Godavari Drugs profit at Rs 11 lakh (May 03, 2009)
SMS Pharma posts Rs 8.69 cr loss (May 03, 2009)
Aurobindo Pharma Q4 net up 18.7% (May 02, 2009)
Suven Life Q4 net down 82% (May 01, 2009)
Biocon Q4 net down 61% on mark-to-market losses (April 29, 2009)
GSK Pharma Q1 net up 18% (April 29, 2009)
Vimta Labs Q4 net up 23% (April 29, 2009)
Strides posts Rs 22-cr standalone profit in Q1 (April 27, 2009)
Wockhardt posts full-year net loss of Rs 139 cr (April 26, 2009)
Forex losses dent Piramal Healthcare’s FY09 net (April 25, 2009)
Ranbaxy posts Rs 777-cr loss in first quarter (April 25, 2009)
Cipla Q4 net profit up on better product-mix (April 25, 2009)
GSK Pharma to increase field-force (February 19, 2009)
Jupiter Bioscience Q3 net slips 4 pc (February 03, 2009)
Anu's Labs net down (February 03, 2009)
Granules India’s Q2 net down (February 03, 2009)
Sun Pharma initiates mediation on Taro (February 01, 2009)
Fresenius Kabi suffers Rs 63-cr loss in Q3 (February 01, 2009)
Orchid Chem posts loss (January 30, 2009)
Lupin net down 35% (January 30, 2009)
Natco Pharma net up 6% (January 29, 2009)
Zydus Cadila consolidated net up 17% (January 29, 2009)
Glenmark consolidated net down 71% (January 28, 2009)
Divis Labs net, revenue down (January 25, 2009)
Ranbaxy reports net loss of Rs 806 cr (January 23, 2009)
Cipla Q3 net up; sales post growth (January 23, 2009)
Piramal Healthcare Q3 net down on forex loss (January 23, 2009)
Novartis net up 7% (January 23, 2009)
Neuland Lab net down 54% (January 23, 2009)
Hikal net rises 8% on higher sales (January 23, 2009)
Biocon standalone Q3 net profit dips 91% (January 22, 2009)
Dr Reddy’s posts Rs 192-cr net in Q3 (January 21, 2009)
Suven Life Q2 net slips 86% (January 21, 2009)
Vimta Labs posts Rs 1.28 cr loss (January 19, 2009)
Astec Lifesciences — IPO: Avoid (November 01, 2009)
Divi’s Laboratories: Buy (October 25, 2009)
Dishman Pharmaceuticals and Chemicals: Buy (October 11, 2009)
Shareholders of Zenotech get fair value in open offer (October 08, 2009)
Ranbaxy to market Daiichi Sankyo’s products in Mexico (October 06, 2009)
Dishman set to benefit from Abbott-Solvay deal (September 30, 2009)
Cadila Healthcare: Buy (September 27, 2009)
Pharma exports grow 29% in 2008-09 (September 26, 2009)
Dr Reddy’s promoters deny stake sale (September 12, 2009)
Now, Novartis moves SC on Glivec patent (August 29, 2009)
SmithKline files patent case against Glenmark (August 19, 2009)
Aurobindo Pharma to acquire group firm Trident Life Sciences for Rs 135 cr (August 18, 2009)
Strides Arcolab ready to supply swine flu drug (August 12, 2009)
Lupin: Buy (August 02, 2009)
Abbott to buy Wockhardt’s nutrition biz for $130 m (July 29, 2009)
Drugmakers keen to blow the whistle on spurious trade (July 29, 2009)
Sanofi buys Merieux stake in Shantha (July 28, 2009)
Drug sector fears bias in Tamiflu sourcing (July 28, 2009)
Pharma’s gen-next gets on board the family business (July 27, 2009)
Daiichi open offer for Zenotech faces legal hurdle (July 16, 2009)
Novartis’ cancer drug is not patentable, says appellate board (July 05, 2009)
Wockhardt to shed more non-core biz (June 30, 2009)
Strides Arcolab (Rs 147.3): Buy (June 28, 2009)
Caraco’s FDA rap to hurt Sun Pharma (June 27, 2009)
Drug patent pool proposal gets a push (June 25, 2009)
Duty cuts sought on cancer, AIDS medicines (June 22, 2009)
Wockhardt sells German biz Esparma (June 18, 2009)
Dr Reddy’s Laboratories to hire 1,300 this year (June 16, 2009)
Dr Reddy’s Laboratories: Buy (June 14, 2009)
Pfizer acquires Vetnex business (June 09, 2009)
16 out of 17 drug consignment seizures in the Dutch were from India (June 08, 2009)
Drug cos expect better access to Japanese market (May 28, 2009)
Malvinder Singh quits Ranbaxy; Atul Sobti made CEO and MD (May 25, 2009)
No one has forced me to resign, says Malvinder (May 25, 2009)
MNC units abroad to come under drug regulator scanner (May 18, 2009)
Piramal Healthcare: Buy (May 17, 2009)
Ranbaxy close to completing trials for new malaria drug (May 05, 2009)
Ranbaxy posts Rs 777-cr loss in first quarter (April 25, 2009)
Cipla does not support Adcock proposal to buy Cipla Medpro (April 19, 2009)
LIC dissents at Pfizer AGM over MD’s salary (April 16, 2009)
Reliance Pharma unit ‘reconfigured’ (April 15, 2009)
The growth potion (April 05, 2009)
Israel's Supreme Court to decide on Sun-Taro spat (April 01, 2009)
Novartis set to raise stake in Indian subsidiary to 90% (March 26, 2009)
Piramal Healthcare: Hold (March 15, 2009)
Merck-Schering Plough deal: What happens to subsidiaries? (March 10, 2009)
Now, pharma exports facing recession blues (March 04, 2009)
US regulator’s action sends Ranbaxy share tumbling 18% (February 27, 2009)
Drug cos applaud rural health mission spend (February 17, 2009)
Piramal Healthcare: Talk of sale to Glaxo `unfounded' (February 08, 2009)
Cipla export consignment too seized at Amsterdam (February 04, 2009)
Central Drug Authority proposal shelved (February 02, 2009)
‘Pfizer, Wyeth operations are complementary’ (January 27, 2009)
Centre plans 40 generic drug stores by March (January 26, 2009)
Drug cos concerned over definition of counterfeits (January 19, 2009)
No reconciliation in sight for Sun-Taro row (January 07, 2009)
Daiichi Sankyo to book losses on Ranbaxy (January 06, 2009)
Taro rebuffs Sun’s revised proposals (January 06, 2009)
Kerala to reward whistleblowers on spurious drug trade (November 18, 2009)
Pharma MNCs campaigning against domestic sector: Sharma (November 12, 2009)
Pharmac expo from today (November 07, 2009)
Pressure on drug makers to work together: PwC (November 07, 2009)
Pharma industry told to aim at zero discharge (October 31, 2009)
Dr Reddy’s in green chemistry body (October 21, 2009)
Coimbatore residents gain from discount war among pharmacies (October 19, 2009)
Animal health players making a beeline for India (October 08, 2009)
Suitable buy: Drug MNCs look at India as a market (October 06, 2009)
Dr Reddy’s recalls lots of 4 products from US (October 01, 2009)
Now, Novartis’ Otrivin spray will be available over the counter (October 01, 2009)
‘Encourage innovation in pharma and healthcare’ (September 29, 2009)
Growing pharma market makes India a clinical trial destination: Report (September 22, 2009)
Singapore woos Indian pharma companies (September 18, 2009)
Gujarat Govt to set up NABL labs (September 07, 2009)
Retail sale of swine flu drug ‘not a done deal’ (September 03, 2009)
Cipla urges Govt to allow retail sale of anti-flu drugs (August 27, 2009)
India emerging global pharma outsourcing hub: Study (August 12, 2009)
20 m more Tamiflu pills to be procured (August 11, 2009)
Pharma sector in good health in June quarter (August 11, 2009)
Combating spurious drugs (August 04, 2009)
Domestic clinical trials market booms (July 26, 2009)
Drug regulator to get more inspectors (July 18, 2009)
Pvt equity, venture capital cos turning to healthcare: Report (July 17, 2009)
Merck to revise labelling on cervical cancer vaccine (July 14, 2009)
Registration to be made mandatory for clinical research organisations (July 12, 2009)
Life-saving drugs to get cheaper (July 07, 2009)
No cheer for pharma, healthcare (July 07, 2009)
Call for deregulation on drug pricing (July 03, 2009)
Patent pool for public health: Breakthrough or Quixotic initiative? (July 01, 2009)
Glenmark’s diabetes drug to enter Phase III trials (June 25, 2009)
Pharma industry seeks incentives for research (June 23, 2009)
Pharma sector told to focus on improving HR quality (June 22, 2009)
Avesthagen in tie-up with Finland centre (June 18, 2009)
Drug cos alerted on swine flu ‘pandemic’ (June 13, 2009)
India asks China to take action on fake drugs issue (June 12, 2009)
Feb pharma exports up 36.7% (June 12, 2009)
US healthcare market set for price reset (June 11, 2009)
Customs duty exemption for Tamiflu drugs (May 28, 2009)
Swine-flu impact: Demand for bio-security products increases (May 25, 2009)
Drug regulator to expand survey on fake medicines (May 22, 2009)
Drug export quality certificate to be issued only by DGCI (May 21, 2009)
Flu drug: Pharma cos asked to report daily stock (May 12, 2009)
Tighter norms for drug clinical trials (May 10, 2009)
Bangalore gets pharma port office (May 07, 2009)
Dr Reddy’s new drug (April 23, 2009)
Pharma exports in better health again (April 20, 2009)
AstraZeneca launches cholesterol drug Crestor (April 17, 2009)
Wockhardt gets breather from ICICI Bank (April 07, 2009)
Emami, Zandu boards form panels to study merger (March 31, 2009)
Novartis open offer starts on May 14 (March 28, 2009)
‘No plans for mergers, acquisitions for now’ (March 27, 2009)
Drug makers get ready to work on vaccine for cervical cancer (March 23, 2009)
Slowdown casts its shadow on pharma sector (March 19, 2009)
Dr Reddy’s wins drug patent case in US (March 14, 2009)
Centre to upgrade Drug Controller office in Gujarat (March 13, 2009)
Microsoft initiative for Hyderabad pharma cluster (March 03, 2009)
39 drug firms under NPPA scanner for overcharging (February 25, 2009)
Wockhardt launches long acting insulin (February 11, 2009)
Study questions local benefits of MNCs’ clinical trials (February 09, 2009)
Study questions local benefits of MNCs’ clinical trials (February 09, 2009)
‘Vaccines market set for explosive growth’ (February 04, 2009)
Stress on collaboration to beat slowdown in pharma sector (February 03, 2009)
Drug prices increased (January 29, 2009)
Paswan asks GoM to take final call on pharma policy (January 27, 2009)
Paswan asks GoM to take final call on pharma policy (January 26, 2009)
Drug firms not rocking Price Waterhouse boat, just yet (January 23, 2009)
Bangalore to host pharma summit on Jan 24 (January 17, 2009)
Price Waterhouse’s pharma clients keeping a close watch (January 14, 2009)
Betapharm blues for Dr Reddy’s (July 19, 2009)
Understanding M&A motives (April 05, 2009)
Ranbaxy Malaysia launches BP drug (August 05, 2009)
Malvinder checks out (May 26, 2009)
‘We will be back to normal soon’ (April 10, 2009)
Cadila launches new TB drug (November 03, 2009)
Suven Life turns more focus on research service tie-ups (October 07, 2009)
Lupin outlicences drug delivery tech to Salix (October 06, 2009)
Avesthagen to raise Rs 850-950 cr from IPO, overseas funds (September 09, 2009)
Generic Tamiflu at select chemists by mid-September (August 29, 2009)
Elder Pharma plans rural thrust (July 09, 2009)
MP Labs accepts exit price for Matrix shares (June 02, 2009)
Amsterdam authorities release Ind-Swift exports (May 23, 2009)
J&J Pharma R&D sets up facility in Mumbai (April 22, 2009)
Piramal Healthcare gets trademark order against 4 cos (April 17, 2009)
Kemwell ties up with Canada’s Patheon (April 04, 2009)
Ranbaxy to market Daiichi Sankyo’s BP drug in India (April 01, 2009)
Elder Pharma shifts focus to local market (March 30, 2009)
Govt moots innovative funding for biotech, pharma sectors (March 21, 2009)
Fourrts India setting up another unit near Chennai (March 15, 2009)
Piramal keen on expanding pharma portfolio (March 13, 2009)
USFDA action against Ranbaxy based on false drug stability data (February 28, 2009)
Shantha Biotechnics to set up new vaccine facility (February 02, 2009)
Year : 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
|
|
RSS Feeds